Microdosing, or low-dose treatment of psychedelics such as lysergic acid diethylamide (LSD), has gained popularity in recent ...

The annual meeting of the American Academy of Dermatology was held from March 7 to 11 in Orlando, Florida, and attracted ...

For adults with severe alopecia areata (AA), ivarmacitinib, a selective Janus kinase 1 (JAK1) inhibitor, at doses o ...

For adults with severe alopecia areata (AA), ivarmacitinib, a selective Janus kinase 1 (JAK1) inhibitor, at doses of 4 and 8 mg is efficacious and tolerable, according to a study presented at the ...

In an alopecia areata trial, a novel bifunctional therapy that blocks signaling of the interleukin-7 and TSLP pathways ...

Oral ivarmacitinib, administered 4 mg or 8 mg once daily, significantly induced hair regrowth at 24 weeks vs. placebo in ...

(MENAFN- GlobeNewsWire - Nasdaq) Dublin, March 04, 2025 (GLOBE NEWSWIRE) -- The "Janus Kinase (JAK) Inhibitor - Pipeline Insight, 2025" drug pipelines has been added to ResearchAndMarkets.com's ...

A panel of 10 expert hematologists created recommendations for optimal MRD-guided ALL treatment, which were recently published in Blood Advances. When acute lymphoblastic leukemia (ALL) occurs in ...

A greater increase in trough FEV1 induced by LAMA was noted in older patients who received a once-daily vs twice-daily regimen. Long-acting muscarinic antagonists (LAMA) significantly improve lung ...

Ulcerative Colitis Market Overview – DelveInsight analyzes prevalence, treatments, and market dynamics across the 7MM. LAS VEGAS , NV, UNITED STATES, January 31 ...